In vitro analysis of the change in resistance of Chlamydia trachomatis under exposure to sub-MIC levofloxacin for a therapeutic term

Chemotherapy

Volumn 46, Issue 6, 2000, Pages 402-407

  Takahashi, Satoshi ^a   Hagiwara, Toshikatsu ^b   Shiga, Sadashi ^b   Hirose, Takaoki ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Chlamydia trachomatis; DNA fingerprinting; Resistance

Indexed keywords

LEVOFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DNA FINGERPRINTING; GENE MUTATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033758596     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007321     Document Type: Article

References (17)

1. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics
2. Relative resistance to erythromycin in Chlamydia trachomatis
3. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure
4. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. Centers for Disease Control and Prevention
5. Characterization of trimethoprim- and sulphisoxazole-resistant Chlamydia trachomatis
6. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro
7. Molecular typing of Chlamydia trachomatis by random amplification of polymorphic DNA
8. Method for in vitro determination of chlamydial susceptibility (minimum inhibitory concentration; MIC) to antimicrobial agents - Standard method of Japan Society of Chemotherapy
9. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
10. In-vitro and in-vivo selection of Staphylococcus aureus mutants resistent to ciprofloxacin
11. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae
12. Compliance declines between clinic visits
13. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers
14. Fingerprinting genomes using PCR with arbitrary primers
15. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting
16. Genomic fingerprinting of Clostridium difficile isolates by using a random amplified polymorphic DNA (RAPD) assay
17. Analysis of cross infection using genomic fingerprinting in nosocomial urinary tract infection caused by Enterococcus faecalis